As we begin to reopen Rush University Medical Center for elective procedures and in-person care, we are putting your safety first. For information about COVID-19, see the latest updates. Rush accepts donations to support our response effort, staff, and patients and families.
Treatment Study for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale
The purpose of the Gore® Cardioform Septal Occluder (GSO device) post-approval study is to assess the continued safety and effectiveness of the FDA-approved GSO device for patent foramen ovale (PFO) closure, and to evaluate the quality of operator education and training and transferability of trial experience to a post-market setting.
In order to participate you must meet the following criteria:
- Have a patent foramen ovale (PFO).
- Have a history of embolic stroke of undetermined source (ESUS) within 365 days prior to enrollment.
- Are 18-70 years old.
You will be excluded from the study if any of the following criteria apply to you:
- Have a history of or ongoing a-fib.
- Have had a previous heart attack.
This is a partial list of inclusion and exclusion criteria.